TMDX
Income statement / Annual
Last year (2024), TransMedics Group, Inc.'s total revenue was $441.54 M,
an increase of 82.74% from the previous year.
In 2024, TransMedics Group, Inc.'s net income was $35.46 M.
See TransMedics Group, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/28/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$441.54 M |
$241.62 M |
$93.46 M |
$30.26 M |
$25.64 M |
$23.60 M |
$13.02 M |
$7.69 M |
$6.21 M |
| Cost of Revenue |
$179.46 M
|
$87.53 M
|
$28.19 M
|
$9.10 M
|
$9.00 M
|
$9.74 M
|
$7.28 M
|
$5.55 M
|
$5.44 M
|
| Gross Profit |
$262.08 M
|
$154.09 M
|
$65.27 M
|
$21.16 M
|
$16.64 M
|
$13.86 M
|
$5.73 M
|
$2.14 M
|
$766,000.00
|
| Gross Profit Ratio |
0.59
|
0.64
|
0.7
|
0.7
|
0.65
|
0.59
|
0.44
|
0.28
|
0.12
|
| Research and Development Expenses |
$55.97 M
|
$63.27 M
|
$26.81 M
|
$22.30 M
|
$18.83 M
|
$19.87 M
|
$13.66 M
|
$14.96 M
|
$15.64 M
|
| General & Administrative Expenses |
$168.62 M
|
$119.55 M
|
$51.69 M
|
$38.28 M
|
$24.19 M
|
$21.52 M
|
$12.32 M
|
$7.61 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$18.21 M
|
$8.60 M
|
$931,000.00
|
$2.07 M
|
$1.02 M
|
$674,000.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$168.62 M
|
$119.55 M
|
$69.90 M
|
$38.28 M
|
$24.19 M
|
$23.60 M
|
$12.32 M
|
$7.61 M
|
$8.12 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.00 M
|
-$877,000.00
|
$1.65 M
|
$790,000.00
|
-$213,000.00
|
$548,000.00
|
$5,000.00
|
| Operating Expenses |
$224.59 M
|
$182.82 M
|
$96.71 M
|
$60.59 M
|
$43.02 M
|
$43.47 M
|
$25.97 M
|
$22.56 M
|
$23.75 M
|
| Cost And Expenses |
$404.04 M
|
$270.35 M
|
$124.90 M
|
$69.69 M
|
$52.02 M
|
$53.21 M
|
$33.25 M
|
$28.11 M
|
$29.20 M
|
| Interest Income |
$0.00
|
$12.50 M
|
$900,000.00
|
$100,000.00
|
$700,000.00
|
$1.00 M
|
$0.00
|
$548,000.00
|
$5,000.00
|
| Interest Expense |
$14.41 M
|
$10.79 M
|
$3.73 M
|
$3.87 M
|
$3.99 M
|
$4.35 M
|
$2.42 M
|
$1.07 M
|
$979,000.00
|
| Depreciation & Amortization |
$19.76 M
|
$8.18 M
|
$4.20 M
|
$2.65 M
|
$1.58 M
|
$1.22 M
|
$769,000.00
|
$630,000.00
|
$426,000.00
|
| EBITDA |
$69.95 M |
-$7.60 M |
-$28.96 M |
-$38.49 M |
-$23.15 M |
-$27.93 M |
-$20.23 M |
-$19.09 M |
-$22.66 M |
| EBITDA Ratio |
0.16
|
-0.03
|
-0.35
|
-1.33
|
-0.96
|
-1.22
|
-1.51
|
-2.5
|
-3.63
|
| Operating Income Ratio |
0.08
|
-0.12
|
-0.34
|
-1.3
|
-1.03
|
-1.25
|
-1.55
|
-2.66
|
-3.7
|
| Total Other Income/Expenses Net |
-$1.72 M
|
$2.06 M
|
-$4.73 M
|
-$4.75 M
|
-$2.33 M
|
-$3.90 M
|
-$3.48 M
|
-$365,000.00
|
-$1.08 M
|
| Income Before Tax |
$35.78 M
|
-$26.67 M
|
-$36.17 M
|
-$44.18 M
|
-$28.72 M
|
-$33.51 M
|
-$23.72 M
|
-$20.79 M
|
-$24.07 M
|
| Income Before Tax Ratio |
0.08
|
-0.11
|
-0.39
|
-1.46
|
-1.12
|
-1.42
|
-1.82
|
-2.71
|
-3.88
|
| Income Tax Expense |
$316,000.00
|
-$1.64 M
|
$66,000.00
|
$36,000.00
|
$32,000.00
|
$40,000.00
|
$41,000.00
|
$32,000.00
|
$984,000.00
|
| Net Income |
$35.46 M
|
-$25.03 M
|
-$36.23 M
|
-$44.22 M
|
-$28.75 M
|
-$33.55 M
|
-$23.76 M
|
-$20.82 M
|
-$24.07 M
|
| Net Income Ratio |
0.08
|
-0.1
|
-0.39
|
-1.46
|
-1.12
|
-1.42
|
-1.82
|
-2.71
|
-3.88
|
| EPS |
1.07 |
-0.77 |
-1.23 |
-1.6 |
-1.16 |
-2.36 |
-1.23 |
-1.44 |
-1.66 |
| EPS Diluted |
1.01 |
-0.77 |
-1.23 |
-1.6 |
-1.16 |
-2.36 |
-1.23 |
-1.44 |
-1.66 |
| Weighted Average Shares Out |
$33.23 M
|
$32.52 M
|
$29.56 M
|
$27.62 M
|
$24.70 M
|
$14.20 M
|
$19.25 M
|
$14.48 M
|
$14.48 M
|
| Weighted Average Shares Out Diluted |
$35.22 M
|
$32.52 M
|
$29.56 M
|
$27.62 M
|
$24.70 M
|
$14.20 M
|
$19.25 M
|
$14.48 M
|
$14.48 M
|
| Link |
|
|
|
|
|
|
|
|
|
